448 results
Page 16 of 23
8-K
EX-99
b9993r4646phi
24 Apr 09
Regulation FD Disclosure
12:00am
8-K
EX-99
dzhc5v1a
22 Apr 09
Results of Operations and Financial Condition
12:00am
8-K
EX-99
h37livn9qmpzbhba4m
6 Apr 09
Regulation FD Disclosure
12:00am
8-K
EX-99
61487aake1
26 Feb 09
Regulation FD Disclosure
12:00am
8-K
EX-99
3ebzsf
12 Feb 09
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
ecjygg7angx2 iel
4 Feb 09
GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma
12:00am
8-K
EX-99.2
eg9o1ozhj5fa34w
4 Feb 09
GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma
12:00am
8-K
EX-99
ht9asfnfm dieqjiu7c
26 Jan 09
Regulation FD Disclosure
12:00am
8-K
EX-99.1
bobu9lz
22 Dec 08
GSK and Theravance Announce Positive Phase 2b Results for LABA ‘444 in the Treatment of COPD in the Horizon Development Programme
12:00am
8-K
EX-99.2
6vlops2z04g 1wxkd
22 Dec 08
GSK and Theravance Announce Positive Phase 2b Results for LABA ‘444 in the Treatment of COPD in the Horizon Development Programme
12:00am
8-K
EX-10.1
1dv45nu3 6rvf4
11 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-99.2
unmerlqcufr4b bm4osx
2 Dec 08
Initial results demonstrate potential of ‘444 in the treatment of patients with moderate to severe asthma
12:00am
8-K
EX-99.1
n4271vk
2 Dec 08
Initial results demonstrate potential of ‘444 in the treatment of patients with moderate to severe asthma
12:00am
8-K
EX-99
duy7nn7yg 5ohgd
19 Nov 08
Regulation FD Disclosure
12:00am
8-K
EX-99
r77oecdq4wc9kde
23 Oct 08
Results of Operations and Financial Condition
12:00am
8-K
EX-99
qd5tmsuq6wap5q21got
14 Oct 08
Regulation FD Disclosure
12:00am